Universal CD7-targeted CAR T-cell therapy in T-ALL: a promising bridge to transplant, but not without caveats—a critical reappraisal - Poll - MDSpire

Universal CD7-targeted CAR T-cell therapy in T-ALL: a promising bridge to transplant, but not without caveats—a critical reappraisal

  • By

  • Qinghua Ke

  • Shiqiong Zhou

  • June 11, 2026

  • 0 min

Share

Original Source(s)

Universal CD7-targeted CAR T-cell therapy in T-ALL: a promising bridge to transplant, but not without caveats—a critical reappraisal

  • by Qinghua Ke, Shiqiong Zhou

  • June 11, 2026

Related Content

Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer

Bulk and single-cell RNA sequencing data identified HMGB3 of chromatin regulators as a breast cancer biomarker associated with the cell cycle

Research progress on the etiology and pathogenesis of pancreatic cancer: a narrative review